Evaluation of Antihypertensive Therapy Among Ischemic Stroke Survivors: Impact of Ischemic Heart Disease

Abstract

Background: Hypertension and ischemic heart disease (IHD) are among the most prevalent modifiable risk factors for stroke. Clinical trial evidence suggests that antihypertensive medications are recommended for prevention of recurrent ischemic stroke in hypertensive and normotensive patients. Objectives: The objectives of this study were to analyze and evaluate the utilization of antihypertensive medication for acute ischemic stroke (AIS) or transient ischemic attack (TIA) survivors in relation to recent recommendations and guidelines and to compare their use among patients with or without IHD. Methods: This was a retrospective cohort study of all patients with AIS/TIA attending the hospital from July 1, 2008 to December 31, 2008. Demographic data, clinical characteristics, different classes of antihypertensive medications, and different antihypertensive combinations prescribed to AIS/TIA survivors were analyzed among patients with and without IHD. Statistical Package for Social Sciences (SPSS) program version 15 was used for data analysis. Results: In all, 383 AIS/TIA survivors were studied, of which 66 (19.5%) had a documented history of IHD. Three quarters (n = 260; 76.9%) of AIS or TIA survivors received antihypertensive medication, mostly as monotherapy, at discharge. The majority of patients (n = 201, 59.5%) were prescribed angiotensin-converting enzyme inhibitors (ACEIs). Patients with IHD were significantly prescribed more β-blockers than patients without IHD (P = .003). A history of hypertension, a history of diabetes mellitus, and age were significantly associated with prescription of antihypertensive medications at discharge (P < .001, P < .001, and P < .001, respectively). Conclusion: Patterns of antihypertensive therapy were commonly but not adequately consistent with international guidelines. Screening stroke survivors for blood pressure control, initiating appropriate antihypertensive medications, and decreasing the number of untreated patients might help reduce the risk of recurrent strokes and increase survival.

Keywords

antihypertensive medications hypertension ischemic heart disease ischemic stroke

References

Rothwell PM , Coull AJ , Silver LE , et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories. Lancet. 2005; 366(9499):1773-1783.

Sacco RL , Adams R. , Albers G. , et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American heart association/American stroke association council on stroke: co-sponsored by the council on cardiovascular radiology and intervention: the American academy of neurology affirms the value of this guideline. Stroke. 2006;113(10):409-449.

Lewington S. , Clarke R. , Qizilbash N. , Peto R. , Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-1913.

Chalmers J. , Todd A. , Chapman N. , et al. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens. 2003;21(4):651-663.

Chobanian AV , Bakris GL , Black HR , et al. Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National heart, lung, and blood institute. National high blood pressure education program coordinating committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206-1252.

PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358(9287):1033-1041.

Hankey G. Long-term outcome after ischemic stroke/transient ischemic attack. Cerebrovasc Dis. 2003;16(Suppl 1):14-19.

Coull A. , Lovett JK , Rothwell PM Population-based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organization of services . BMJ. 2004;328(7435):326.

Rosendorff C. , Black HR , Cannon CP , et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115(21):2761-2788.

10.

WHO task force on stroke and other cerebrovascular disorders. Recommendations on stroke prevention, diagnosis, and therapy. Stroke. 1989;20(10):1407-1431.

11.

Hajat C. , Dundas R. , Stewart JA , et al. Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke. 2001;32(1):37-42.

12.

Pinto A. , Tuttolomondo A. , Di Raimondo D. , Fernandez P. , Licata G. Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med. 2004;4(3):287-303.

13.

Straus SE , Majumdar SR , McAlister FA New evidence for stroke prevention: scientific review. JAMA . 2002;288(11): 1388-1395.

14.

Hillen T. , Dundas R. , Lawrence E. , Stewart JA , Rudd AG , Wolfe CD Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke. 2000;31(2):469-475.

15.

Law M. , Wald NJ , Morris JK , Jordan RE Value of low-dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003 ;326(7404):1427.

16.

Lindenauer PK , Mathew MC , Ntuli TS , Pekow PS , Fitzgerald J. , Benjamin EM Use of antihypertensive agents in the management of patients with acute ischemic stroke. Neurology. 2004;63(2): 318-323.

17.

Ovbiagele B. , Hills NK , Saver JL , Johnston SC Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event. Stroke. 2005;36(9):1944-1947.

18.

Sweileh WM , Sawalha AF , Zyoud SH , Al-Jabi SW Antihypertensive therapy for acute ischemic stroke survivors. CVD Prevention Control. 2009;4(3):171-175.

19.

Fukuda D. , Enomoto S. , Nagai R. , Sata M. Inhibition of reninangiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation. Biomed Pharmacother . 2009;63(10):754-761.

20.

Dahlof B. , Devereux RB , Kjeldsen SE , et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 2002;359(9311):995-1003.

21.

Selim M. , Savitz S. , Linfante I. , Caplan L. , Schlaug G. Effect of prestroke use of ACE inhibitors on ischemic stroke severity. BMC Neurol. 2005;5(1):10.

22.

Chitravas N. , Dewey HM , Nicol MB , Harding DL , Pearce DC , Thrift AG Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Neurology . 2007; 68(20):1687-1693.

23.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes mellitus (UKPDS 33). Lancet. 1998;352(9131):837-853.

24.

MacMahon S. , Rodgers A. Blood pressure, antihypertensive treatment and stroke risk. J Hypertens. 1994;12(10):5-14.

25.

Qureshi A. , Suri MF , Guterman LR , Hopkins LN Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2001;161(13):1621-1628.

26.

Gibbons RJ , Abrams J. , Chatterjee K. , et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol. 2003;41(1):159-168.

27.

Sweileh WM , Sawalha AF , Zyoud SH , Al-Jabi SW , Tameem EJ , Shraim NY Evaluation of antihypertensive therapy in diabetic hypertensive patients: impact of ischemic heart disease. Pharm Pract. 2009;7(1):40-46.

28.

Ruland S. , Gorelick PB Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor? Curr Neurol Neurosci Rep. 2003;3(1):21-26.